Observational Study in COVID-19 Patients Treated With Remdesivir (RECOVER)

Fadoi Foundation, Italy

Status: Completed

Conditions: Hospitalization

Treatments: Other: no experimental intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05239988

FADOI.02.2021

Details and patient eligibility

About

Taking into account the high number of COVID-19 patients managed in Italian Internal Medicine, Fadoi Foundation (Italian Scientific Society of Internal Medicine) promotes a national retrospective observational study in patients treated with Remdesivir, analyzing the characteristics of patients and their clinical outcome during hospitalization, and thus providing real-life information potentially useful to integrate the evidence produced by studies conducted under experimental conditions and available in the literature.

Full description

This is a multicenter observational, retrospective study, which involves the participation of 35 Nationally Representative Internal Medicine Units, for each center data on all patients suffering from SARS-CoV-2 and treated with Remdesivir are expected to be recorded. Each center will have the task of collecting the data of patients hospitalized consecutively proceeding backwards until March 2020.

The study is a no-profit scientific project, promoted by The FADOI Foundation, the Scientific Society of Internal Medicine.

Enrollment: 1,004 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients aged ≥ 18 years
• diagnosed with radiologically documented SARS-CoV-2 pneumonia
• treated with Remdesivir (according to the criteria defined by AIFA*)
• admitted to Internal Medicine from March 2020 to August 2021.

Exclusion criteria

• none

Trial design

1,004 participants in 1 patient group

COVID-19 patients treated with Remdesivir

Description:

Patients suffering from SARS-CoV-2 and treated with Remdesivir admitted to Internal Medicine Unit

Treatment:

Other: no experimental intervention